QQ客服 官方微博 反馈留言

	The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.
	Zhu, Yuxing; He, Dong; Bo, Hao; Liu, Zexian; Xiao, Mengqing; Xiang, Liang; Zhou, Jianda; Liu, Yan; Liu, Xiaoming; Gong, Lian
刊名	Oncogene
	2019
卷号	38期号:32页码:6065-6081
ISSN号	0950-9232
DOI	10.1038/s41388-019-0858-7
URL标识	查看原文
WOS记录号	WOS:000480329900005
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5708104
专题	湖南中医药大学
作者单位	1.[Xiang, Liang 2.Zhu, Yuxing 3.Cao, Ke 4.Ma, Yanni 5.Xiao, Mengqing 6.Gong, Lian] Cent S Univ, Dept Oncol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Zhu, Yuxing,He, Dong,Bo, Hao,et al. The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.[J]. Oncogene,2019,38(32):6065-6081.
APA	Zhu, Yuxing.,He, Dong.,Bo, Hao.,Liu, Zexian.,Xiao, Mengqing.,...&Cao, Ke*.(2019).The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway..Oncogene,38(32),6065-6081.
MLA	Zhu, Yuxing,et al."The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.".Oncogene 38.32(2019):6065-6081.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。